Results for
"[search-keyword]"
Sponsor content
315 result(s) found, displaying 1 to 10
-
Dec-2024Prescription medicine evaluationActive ingredient: Influenza virus.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Nov-2024Prescription medicine evaluationActive ingredient: trastuzumab deruxtecan.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARX-Ticagrelor ticagrelor 90 mg tablet blister pack.
-
Australian Public Assessment Report (AusPAR)LOKELMA (sodium zirconium cyclosilicate hydrate) has been approved for the treatment of hyperkalaemia (high potassium levels in blood) in adult patients.
-
Australian Public Assessment Report (AusPAR)Enhertu (trastuzumab deruxtecan) has been approved to treat adult patients with unresectable or metastatic HER2-low breast cancer.
-
Sep-2024Prescription medicine evaluationActive ingredient: trastuzumab deruxtecan.
-
Sep-2024Prescription medicine evaluationActive ingredient: sipavibart.